rs6013281
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_020436.5(SALL4):āc.540T>Cā(p.Asn180=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.996 in 1,614,230 control chromosomes in the GnomAD database, including 800,103 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 1.0 ( 75670 hom., cov: 34)
Exomes š: 1.0 ( 724433 hom. )
Consequence
SALL4
NM_020436.5 synonymous
NM_020436.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.406
Genes affected
SALL4 (HGNC:15924): (spalt like transcription factor 4) This gene encodes a zinc finger transcription factor thought to play a role in the development of abducens motor neurons. Defects in this gene are a cause of Duane-radial ray syndrome (DRRS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 20-51791943-A-G is Benign according to our data. Variant chr20-51791943-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 261264.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-51791943-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.406 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.99 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SALL4 | NM_020436.5 | c.540T>C | p.Asn180= | synonymous_variant | 2/4 | ENST00000217086.9 | |
SALL4 | NM_001318031.2 | c.540T>C | p.Asn180= | synonymous_variant | 2/4 | ||
SALL4 | XM_047440318.1 | c.234T>C | p.Asn78= | synonymous_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SALL4 | ENST00000217086.9 | c.540T>C | p.Asn180= | synonymous_variant | 2/4 | 1 | NM_020436.5 | P1 | |
SALL4 | ENST00000395997.3 | c.540T>C | p.Asn180= | synonymous_variant | 2/4 | 1 | |||
SALL4 | ENST00000371539.7 | c.131-2802T>C | intron_variant | 1 | |||||
SALL4 | ENST00000483130.1 | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.997 AC: 151717AN: 152220Hom.: 75610 Cov.: 34
GnomAD3 genomes
AF:
AC:
151717
AN:
152220
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.997 AC: 250539AN: 251400Hom.: 124844 AF XY: 0.996 AC XY: 135372AN XY: 135870
GnomAD3 exomes
AF:
AC:
250539
AN:
251400
Hom.:
AF XY:
AC XY:
135372
AN XY:
135870
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.996 AC: 1455361AN: 1461892Hom.: 724433 Cov.: 93 AF XY: 0.995 AC XY: 723929AN XY: 727246
GnomAD4 exome
AF:
AC:
1455361
AN:
1461892
Hom.:
Cov.:
93
AF XY:
AC XY:
723929
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.997 AC: 151836AN: 152338Hom.: 75670 Cov.: 34 AF XY: 0.997 AC XY: 74268AN XY: 74484
GnomAD4 genome
AF:
AC:
151836
AN:
152338
Hom.:
Cov.:
34
AF XY:
AC XY:
74268
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3473
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 16, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Duane-radial ray syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Oculootoradial syndrome;C1623209:Duane-radial ray syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 23, 2021 | - - |
Oculootoradial syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at